I thought we already completed the phase 3 trial for mono with great results. Our goal was a label extension after we achieved combo HIV approval… no other trials were necessary as Nader said it… hmmmm? Results of audit? Hope not… I am expecting good to great things once we have reviewed the total information available from the audit.